McCormick, N., Burrack, N., Yokose, C., Lu, N., Wexler, D. J., Rai, S. K., . . . Choi, H. K. (2026). Gout-Related Medication Use After Initiating Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies. Diabetes Care, 49(3), 460. https://doi.org/10.2337/dc25-1713
Chicago Style (17th ed.) CitationMcCormick, Natalie, et al. "Gout-Related Medication Use After Initiating Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies." Diabetes Care 49, no. 3 (2026): 460. https://doi.org/10.2337/dc25-1713.
MLA (9th ed.) CitationMcCormick, Natalie, et al. "Gout-Related Medication Use After Initiating Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies." Diabetes Care, vol. 49, no. 3, 2026, p. 460, https://doi.org/10.2337/dc25-1713.